FREE Account Opening + No Clearing Fees

Advanced Enzyme Technologies Ltd IPO (Advanced Enzyme IPO) Detail

July 20, 2016 - July 22, 2016

Advanced Enzyme IPO is a book built issue of Rs 411.49 crores. The issue comprises of fresh issue of Rs 50.00 crore and offer for sale of 0.4 crore shares.

Advanced Enzyme IPO bidding started from July 20, 2016 and ended on July 22, 2016. The shares got listed on BSE, NSE on August 1, 2016.

Advanced Enzyme IPO price band is set at ₹880 to ₹896 per share. The minimum lot size for an application is 16 Shares. The minimum amount of investment required by retail investors is ₹14,336.

Axis Capital Limited and ICICI Securities Limited are the book running lead managers of the Advanced Enzyme IPO, while Link Intime India Private Ltd is the registrar for the issue.

Refer to Advanced Enzyme IPO RHP for detailed information.

Advanced Enzyme IPO Details

IPO Date July 20, 2016 to July 22, 2016
Listing Date August 1, 2016
Face Value ₹10 per share
Price Band ₹880 to ₹896 per share
Lot Size 16 Shares
Total Issue Size4,594,875 shares
(aggregating up to ₹411.49 Cr)
Fresh Issue[.] shares
(aggregating up to ₹50.00 Cr)
Offer for Sale4,034,470 shares of ₹10
(aggregating up to ₹[.] Cr)
Issue Type Book Built Issue IPO
Listing At BSE, NSE

Advanced Enzyme IPO Reservation

Advanced Enzyme IPO offers 3,234,059 shares. 918,908 (28.41%) to QIB, 686,989 (21.24%) to NII, 1,602,974 (49.57%) to RII, 25,188 (0.78%) to employees. 100,185 RIIs will receive minimum 16 shares and (sNII) and (bNII) will receive minimum 224 shares. (in case of oversubscription)

Investor Category Shares OfferedMaximum Allottees
Anchor Investor Shares Offered-NA
QIB Shares Offered918,908 (28.41%)NA
NII (HNI) Shares Offered686,989 (21.24%)
Retail Shares Offered1,602,974 (49.57%)100,185
Employee Shares Offered25,188 (0.78%)NA
Total Shares Offered3,234,059 (100%)

Advanced Enzyme IPO Lot Size

Investors can bid for a minimum of 16 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (Min) 1 16 ₹14,336
Retail (Max) 13 208 ₹186,368
Lot Size Calculator

About Advanced Enzyme Technologies Ltd

Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products. Information in this paragraph is copied from

Company produces over 400 proprietary products developed from 60 enzymes. Advanced Enzyme operate in two primary business verticals namely Healthcare & Nutrition (human and animal) and Bio-Processing (food and non-food).

Company has 13 patents registered in its name and applications for registration of 4 patents are pending.

Advanced Enzyme is among top 15 companies in enzyme sales in the world and 2nd largest in India. Company has over 20 years of fermentation experience in the production of enzymes. Company offer these products to its more than 700 global customers across 50 countries around the world. Content in this paragraph is copied from

Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.

Competitive strengths of the company:

1. Integrated Company with presence across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows

Company Financials

Summary of financial Information
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 4,516.50 4,180.92 4,082.76 3,963.47 3,490.09
Total Revenue 2,946.37 2,242.69 2,404.81 2,241.15 1,748.78
Profit After Tax (PAT) 784.35 501.02 200.86 492.19 333.36

Objects of the Issue (Advanced Enzyme IPO Objectives)

The Offer consists of a Fresh Issue by the company and an Offer for Sale by the Selling Shareholders.

1. Offer for Sale
Company will not receive any proceeds from the Offer for Sale.

2. The Fresh Issue
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.

Advanced Enzyme IPO Review (Apply)

[Dilip Davda]  Being first mover IPO in the enzymes segment, it is catching fancy. Considering its track records and future prospects ahead, investors may consider investment for short to long term rewards. Read detail review...

Advanced Enzyme IPO Subscription Status (Bidding Detail)

The Advanced Enzyme IPO is subscribed 116.02 times on July 22, 2016 5:00:00 PM. The public issue subscribed 11.67 times in the retail category, 94.03 times in the QIB category, and 393.10 times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Advanced Enzyme IPO Prospectus

Advanced Enzyme IPO Rating

Rating:Rated 3.9 stars
Vote Here ...

Advanced Enzyme IPO Listing Details

Listing Date August 1, 2016
BSE Script Code 540025
ISIN INE837H01012
Final Issue Price ₹896 per share

Pre-Open Session - NSE Pre-Open Session - BSE

Listing Day Trading Information

Price Details
Final Issue Price
Last Trade

Check IPO Performance…

Advanced Enzyme Technologies Ltd Contact Details

Advanced Enzyme Technologies Ltd
Sun Magnetica, 5th Floor,
Near LIC Service Road, Louiswadi,
Thane 400604, Maharashtra, India
Phone: +91-22-4170 3200

Advanced Enzyme IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270

Advanced Enzyme IPO - Buy or Not

Advanced Enzyme IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 6 0 0
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

Advanced Enzyme IPO FAQs

Advanced Enzyme IPO is a main-board IPO of 4,594,875 equity shares of the face value of ₹10 aggregating up to ₹411.49 Crores. The issue is priced at ₹880 to ₹896 per share. The minimum order quantity is 16 Shares.

The IPO opens on July 20, 2016, and closes on July 22, 2016.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

The Advanced Enzyme IPO opens on July 20, 2016 and closes on July 22, 2016.

Advanced Enzyme IPO lot size is 16 Shares, and the minimum amount required is ₹14,336.

You can apply in Advanced Enzyme IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Advanced Enzyme IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Advanced Enzyme IPO allotment status.

The Advanced Enzyme IPO listing date is on August 1, 2016.
Open an Instant Account with Zerodha

Advanced Enzyme IPO Message Board

Ranked Members of Forum  Ranked Members | Members with Most Likes



1137. MARKET KING |   Link |  Bookmark |September 27, 2016 4:39:17 PM
applied through axis bank still not alloted and appliction number is of only 7 digit.
1136. LUCKYYYY |   Link |  Bookmark |September 20, 2016 8:17:58 PM
Alkem lab eps for Q1 21.04 ....omg !!!

Estimate 21.04*4 =84.16 *25(pE)==2104...

Even if eps goes to near 75 then also 25*75 == 1875


Buy on every 50-70 rs drop.

Estimate 21.04*4 =84.16 *25(pE)==2104...

Sir plz give info related to *25(PE) where can i found this...(price to earning) can we know this
1135. MA |   Link |  Bookmark |September 16, 2016 2:13:52 PM
Thanks and Congrats Eagleye. Target of Rs.1600 achieved.
1134. sunilkarma |   Link |  Bookmark |September 16, 2016 12:48:27 PM
if you have no pan card for this process or having pan card but created issue so use of this site for pan card
1133. ARATII |   Link |  Bookmark |September 11, 2016 8:04:13 AM
1132. HiteshS |   Link |  Bookmark |August 29, 2016 2:33:48 PM
Allotted but no money is deducted.
How is that possbile???
1131. ABHAY KUMAR |   Link |  Bookmark |August 16, 2016 4:24:37 PM
buy on 1485, can i hold it..................
1130. Indy |   Link |  Bookmark |August 12, 2016 11:30:58 AM
How IPO shares gets allotted to retail investors
Some retail investors who recently applied for IPOs are confused because they did not receive even a single lot of shares despite subscribing to the full quota of Rs 2 lakh
Shishir Asthana       | Mumbai
December 21, 2015 Last Updated at 16:26 IST
Tiny URL Add to My Page Print Email AddThis Sharing Buttons28326

How IPO shares gets allotted to retail investors
Healthcare floats draw strong investor response
Dr Lal PathLabs: Diagnostics at a premium valuations
Alkem Lab: A new formula for investors
Focus on pharma IPOs next week
Country''s oldest path lab chain to go public with Rs 638-cr IPO

A series of recent initial public offerings (IPO) saw good participation by retail investors. In almost all the good issues, the quota for retail investors was oversubscribed. This is a good signal for the market as it shows significant interest from investors in equity as an asset class.

However, retail investors who had applied for some recent IPOs seem more confused as there is no logical explanation to the manner in which shares were allotted. For example, in the issues of Alkem Labs and Dr Lal Pathlabs, where retail portion was oversubscribed over three times, several retail investors have complained they did not receive even a single lot of shares despite subscribing to the full quota of Rs 2 lakh.

The method used to allot shares were changed in 2012 by the Securities and Exchange Board of India (Sebi). But the allotment process has come under investor scrutiny as there is renewed interest in some of the high-quality issues in the recent times.

In order to understand the rationale behind the allocation, we need to look at the guidelines issued by Sebi. Firstly, we need to understand that applications are segregated into three categories -- institutional or qualified institutional buyer (QIB), NII (non-institutional investors) or HNI (High-networth investor) and retail individual investor (RII).

In the case of QIB, the merchant banker has the discretion to allot shares. In the case of QIB, shared are allotted proportionately. Thus, if shares are oversubscribed by say, five times then an application for 1,000,000 shares will receive only 200,000 lakh shares.

But when it comes to retail investors, the process is a little more complex. First of all, only RII are allowed to invest in smaller lots worth between Rs 10,000-15,000 as compared to Rs 5,000-7,000 before 2012. A maximum of Rs 2 lakh per IPO can be applied by an applicant in the RII category.

The total number of applications received in the RII category is grouped together to determine the total demand in this category. If the aggregate demand in this category is less than or equal to the retail portion at or above the offer price (in case of a book-build operation), full allotment may be made to the RIIs to the extent of the valid bids.

However, if demand in this category is greater than the allocation in the retail portion at or above the offer price, then the maximum number of RIIs who can be allotted the minimum bid lot will be computed by dividing the total number of equity shares available for allotment to RIIs by the minimum bid lot, this is known as ‘Maximum RII Allottees’.

Assuming that there are shares worth Rs 10 lakh to be allotted in retail segment and the minimum lot size is worth Rs 10,000. Thus only a maximum of 100 applicants will be receiving the minimum lot of Rs 10,000. Since Sebi says that no RII will be allotted less than the minimum bid lot, in case of over subscription, allocation of shares lower than the minimum lot is not possible. In this case, the Maximum RII Allottees are 100.

In case there is a small oversubscription then first the minimum lot is distributed among all participants and then the balance available equity shares in the retail portion shall be allotted proportionately to the RIIs who have bid for more than one minimum bid lot.

But in case the number of RIIs is more than Maximum RII Allottees, the RIIs (in that category) who will then be allotted minimum bid lot shall be determined on the basis of draw of lots. The draw of lots is now a computerised process and thus there is no room for partiality.
1130.1. RR Choudhary |   Link |  Bookmark |August 12, 2016 6:53:41 PM
great sir

done a good job to explain

tks a lot.
1129. Saurish |   Link |  Bookmark |August 12, 2016 11:19:19 AM
Eagleye Should we hold advance enzyme
1128. Bigbull |   Link |  Bookmark |August 10, 2016 6:17:39 PM
RBL bank IPO open on 19 August to 23 August. Price band 224-225. Lot-65.Face value 10.
1127. RR Choudhary |   Link |  Bookmark |August 10, 2016 2:31:43 PM
no reply from any one?
1127.2. Indy |   Link |  Bookmark |August 12, 2016 7:28:55 AM
1127.3. RR Choudhary |   Link |  Bookmark |August 12, 2016 6:43:35 PM
tks sir
1126. RR Choudhary |   Link |  Bookmark |August 9, 2016 9:04:55 PM
Dear Sir,

I have applied for Adv Enz Tech IPO for rs. 185000 appx for i hope 13 lot at cut off price. this was max bcz next lot was crossing 2lac which is limit for retail investor

I did not rcvd single lot.

Is it possible and fair?

Req ack
1126.2. Profitable Rocky |   Link |  Bookmark |August 12, 2016 10:21:11 AM
Dear R R Choudhary , According to SEBI if IPO is oversubscribed in retail category, then retail investor will get max 1 lot. So no point of applying for more than 1 lot. Hope you understood.
1126.3. RR Choudhary |   Link |  Bookmark |August 12, 2016 6:42:26 PM
tks sir
1125. NRI Investor |   Link |  Bookmark |August 8, 2016 11:21:59 PM
Top Contributor Top Contributor (200+ Posts, 300+ Likes)
Advanced Enzyme Shares going up daily basis..

What is short term target for AET now ?

Whats best price to sell for short term ???
1124. gamble |   Link |  Bookmark |August 8, 2016 3:38:54 PM (1600+ Posts, 3900+ Likes)
Look like accuracy is increasing by 95%....
Check past 15 days...almost everyday up....

1100. gamble Aug 4, 2016 10:48:53 AM IST Reply
If u r intraday trader. ...try to trade in MGL...with SL
1.5%-2% gain is sureshot.....90% accuracy ...avoid in just big negative session.
1124.1. gamble |   Link |  Bookmark |August 9, 2016 9:04:09 PM (1600+ Posts, 3900+ Likes)
Now accuracy 99%...
Hit 547 intraday.
1123. nayan lakhani |   Link |  Bookmark |August 6, 2016 8:51:39 AM
When will be the result of AET?
1123.1. Khemka |   Link |  Bookmark |August 6, 2016 9:12:07 AM (1000+ Posts, 400+ Likes)
Probably October
1122. Lahari |   Link |  Bookmark |August 5, 2016 12:23:09 PM (300+ Posts, 300+ Likes)
The current revenues are with 40% utilization. If they reach goal 100% utilization in next FY17.Huge jump in profits. HOLD tight for long term
1121. gamble |   Link |  Bookmark |August 4, 2016 10:48:53 AM (1600+ Posts, 3900+ Likes)
If u r intraday trader. ...try to trade in MGL...with SL
1.5%-2% gain is sureshot.....90% accuracy ...avoid in just big negative session.
1120. gamble |   Link |  Bookmark |August 4, 2016 9:28:41 AM (1600+ Posts, 3900+ Likes)
What a fall in nifty !!
1119. arbandyo |   Link |  Bookmark |August 3, 2016 6:46:44 PM
No allotment last five IPOs thanks to link not in time.
1118. VIPULCHAU |   Link |  Bookmark |August 3, 2016 2:54:35 PM
latest subscription DBL ?